Major limitations in the use of cationic liposomes for DNA delivery
- 1 March 1998
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 162 (1-2) , 159-170
- https://doi.org/10.1016/s0378-5173(97)00423-7
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Fate of cationic liposomes and their complex with oligonucleotive in vivoBiochimica et Biophysica Acta (BBA) - Biomembranes, 1996
- The estrogen antagonist tamoxifen inhibits carrageenan induced inflammation in LEW/N female ratsLife Sciences, 1996
- Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into ratsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Nitric oxide, a vital poison inside the immune and inflammatory networkResearch in Immunology, 1995
- Differential Effects of PKC Inhibitors on Gelatinase B and Interleukin 6 Production in the Mouse MacrophageCytokine, 1995
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- Assessment of ocular irritability of liposome preparations. .Journal of Pharmacobio-Dynamics, 1988
- Impairment of immunogenicity by antigen presentation in liposomes made from dimyristoylphosphatidyl‐ethanolamine linked to the secretion of prostaglandins by macrophagesEuropean Journal of Immunology, 1987
- Liposomes induce chromosome aberrations in human cultured cellsExperimental Cell Research, 1985
- Immunomodulating properties of two synthetic adjuvants: Dependence upon type of antigen, dose, and time of administrationCellular Immunology, 1984